Emergence of institutional antithrombotic protocols for coronavirus 2019.

Cohoon, Kevin P; Mahé, Guillaume; Tafur, Alfonso J; Spyropoulos, Alex C

Cohoon, Kevin P; Mahé, Guillaume; Tafur, Alfonso J; Spyropoulos, Alex C.

Cohoon KP; Division of Cardiovascular Medicine Department of Medicine Froedtert and Medical College of Wisconsin Milwaukee Wisconsin USA.
Mahé G; CHU de Rennes, unité de médecine vasculaire Rennes France.
Tafur AJ; Inserm, CIC 1414 Univ Rennes, CHU Rennes Rennes France.
Spyropoulos AC; Pritzker School of Medicine at the University of Chicago Chicago Illinois USA.

Res Pract Thromb Haemost ; 4(4): 510-517, 2020 May.

Artigo em Inglês | MEDLINE | ID: covidwho-601438

Palavras-chave

COVID19; SARSCoV2; acute infectious disease; anticoagulant; antiplatelet; antithrombotic therapy; coronavirus; deep vein thrombosis; pulmonary embolism; pulmonary infection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Idioma: Inglês Revista: Res Pract Thromb Haemost Ano de publicação: 2020 Tipo de documento: Artigo

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google